News & Updates

A single dose of nirsevimab administered before or during the respiratory syncytial virus (RSV) season provides protection against RSV lower respiratory tract infection (LRTI) hospitalization and very severe infection in infants, according to the preliminary results of a clinical trial conducted in real-world settings.

Ocular hypertension (OHT) and macular edema (ME) are the most common and relevant adverse events (AEs) following neodymium:yttrium-aluminum-garnet posterior capsulotomy (Nd:YAG-caps), reports a study. These AEs normally occur within 3 months after the procedure, which stresses the need for a close follow-up during this period or a delayed capsulotomy.

High and low levels of serum potassium appear to contribute to an increase in the risk of death or kidney failure requiring replacement therapy (KRT) among older patients with chronic kidney disease (CKD) stage 4‒5, according to a study.

Children with Lennox-Gastaut syndrome (LGS) and Dravet's syndrome (DS) achieve improvements in both seizure management and nonseizure outcomes following treatment with cannabidiol (CBD)—a success echoed in their adult counterparts, as shown in a study presented at AAN 2023.

Use of dexmedetomidine has lessened the effective concentration (EC50) of propofol administered via plasma target-controlled infusion (TCI) during gastrointestinal endoscopy, a study has found. A 0.5‒1 μg/kg dose of dexmedetomidine results in a lower heart rate (HR) without bradycardia.